MedPath

Apollo Neuroscience, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

Not Applicable
Recruiting
Conditions
Stress Disorders, Post-Traumatic
First Posted Date
2022-03-10
Last Posted Date
2023-02-02
Lead Sponsor
Apollo Neuroscience, Inc.
Target Recruit Count
200
Registration Number
NCT05274230
Locations
🇺🇸

Apollo Neuroscience, Inc., Pittsburgh, Pennsylvania, United States

Apollo Remote Observational Sleep Study

Withdrawn
Conditions
Heart Rate
Sleep Quality
First Posted Date
2022-03-02
Last Posted Date
2024-07-09
Lead Sponsor
Apollo Neuroscience, Inc.
Registration Number
NCT05260489
Locations
🇺🇸

Apollo Neuroscience, Inc., Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.